107 related articles for article (PubMed ID: 8266318)
21. A new monoclonal antibody recognizing a linear determinant on the HLA-DRalpha chain N-terminus.
Ting YT; Temme S; Koch N; McLellan AD
Hybridoma (Larchmt); 2009 Dec; 28(6):423-9. PubMed ID: 20025501
[TBL] [Abstract][Full Text] [Related]
22. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
Karp DR; Long EO
J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
[TBL] [Abstract][Full Text] [Related]
23. Combinatorial diversity in DR2 haplotypes.
Wade JA; Hurley CK; Hastings A; Ehrenberg P; Johnson AH; Martell RW; du Toit ED
Tissue Antigens; 1993 Mar; 41(3):113-8. PubMed ID: 8316942
[TBL] [Abstract][Full Text] [Related]
24. Properties of HLA class II molecules divergently associated with Goodpasture's disease.
Phelps RG; Jones V; Turner AN; Rees AJ
Int Immunol; 2000 Aug; 12(8):1135-43. PubMed ID: 10917888
[TBL] [Abstract][Full Text] [Related]
25. A novel HLA-haplotype containing a DRB5 gene not associated with DRB1*15 or DRB1*16 alleles.
Tautz C; Marsh DG; Baur X
Tissue Antigens; 1992 Feb; 39(2):91-4. PubMed ID: 1574803
[TBL] [Abstract][Full Text] [Related]
26. Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells.
Ooi JD; Petersen J; Tan YH; Huynh M; Willett ZJ; Ramarathinam SH; Eggenhuizen PJ; Loh KL; Watson KA; Gan PY; Alikhan MA; Dudek NL; Handel A; Hudson BG; Fugger L; Power DA; Holt SG; Coates PT; Gregersen JW; Purcell AW; Holdsworth SR; La Gruta NL; Reid HH; Rossjohn J; Kitching AR
Nature; 2017 May; 545(7653):243-247. PubMed ID: 28467828
[TBL] [Abstract][Full Text] [Related]
27. A monoclonal mouse anti-rat Ia antibody which cross reacts with a human HLA-DRw determinant.
McMaster WR; Winearls BC; Parham P
Tissue Antigens; 1979 Nov; 14(5):453-8. PubMed ID: 12731578
[TBL] [Abstract][Full Text] [Related]
28. Cross-linking of a sequential epitope within the beta-chain of HLA-DR/DP molecules suppressing B lymphocyte growth and inducing homotypic cell aggregation.
Ghaderi AA; Gaudernack G; Stanworth DR
Immunol Lett; 1994 Feb; 39(2):113-9. PubMed ID: 7516911
[TBL] [Abstract][Full Text] [Related]
29. Evolutionary relationship between human major histocompatibility complex HLA-DR haplotypes.
Svensson AC; Setterblad N; Pihlgren U; Rask L; Andersson G
Immunogenetics; 1996; 43(5):304-14. PubMed ID: 9110934
[TBL] [Abstract][Full Text] [Related]
30. Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes.
Erlich HA; Griffith RL; Bugawan TL; Ziegler R; Alper C; Eisenbarth G
Diabetes; 1991 Apr; 40(4):478-81. PubMed ID: 2010048
[TBL] [Abstract][Full Text] [Related]
31. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
Vogt AB; Kropshofer H; Kalbacher H; Kalbus M; Rammensee HG; Coligan JE; Martin R
J Immunol; 1994 Aug; 153(4):1665-73. PubMed ID: 7519208
[TBL] [Abstract][Full Text] [Related]
32. Diversity in the fine specificity and idiotypic profile of mouse anti-HLA-DR monoclonal antibody elicited with the syngeneic anti-idiotypic monoclonal antibody F5-830.
Mariani SM; Armandola EA; Ferrone S
J Immunol; 1991 Aug; 147(4):1322-30. PubMed ID: 1714480
[TBL] [Abstract][Full Text] [Related]
33. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses.
Lechler RI; Heaton T; Barber L; Bal V; Batchelor JR; Lombardi G
Immunol Lett; 1992 Sep; 34(1):63-9. PubMed ID: 1478706
[TBL] [Abstract][Full Text] [Related]
34. Binding motifs of copolymer 1 to multiple sclerosis- and rheumatoid arthritis-associated HLA-DR molecules.
Fridkis-Hareli M; Neveu JM; Robinson RA; Lane WS; Gauthier L; Wucherpfennig KW; Sela M; Strominger JL
J Immunol; 1999 Apr; 162(8):4697-704. PubMed ID: 10202010
[TBL] [Abstract][Full Text] [Related]
35. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
López D; Barber DF; Villadangos JA; López de Castro JA
J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
[TBL] [Abstract][Full Text] [Related]
36. A cross-reactive mouse anti-I-Ek monoclonal antibody detects an HLA-DR polymorphism linked to HLA-DR1.
Birnbaum D; Dosseto M; Bourgue F; Pierres M; Kourilsky FM
Mol Immunol; 1982 Jun; 19(6):755-64. PubMed ID: 6981060
[No Abstract] [Full Text] [Related]
37. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
Newton-Nash DK; Eckels DD
J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
[TBL] [Abstract][Full Text] [Related]
38. Selective PCR-RFLP method to distinguish HLA-DR1 from HLA-DR-"Br" (Dw Bon) alleles: applications in clinical histocompatibility testing.
Bignon JD; Cesbron A; Cheneau ML; Bonneville F; Herry P; Muller JY
Tissue Antigens; 1990 Oct; 36(4):171-3. PubMed ID: 1981816
[No Abstract] [Full Text] [Related]
39. The combination of HLA-DR1 and HLA-DR53 protects against MS.
Luomala M; Elovaara I; Ukkonen M; Koivula T; Lehtimäki T
Neurology; 2001 Feb; 56(3):383-5. PubMed ID: 11171905
[TBL] [Abstract][Full Text] [Related]
40. A mouse monoclonal antibody against a polymorphic determinant in a defined subset of DR molecules.
Mazzilli MC; Tanigaki N; Cascino I; Costanzi Porrini S; Trabace S; Cappellacci S; Testa L; Gandini E
Hum Immunol; 1986 Jun; 16(2):148-56. PubMed ID: 2424872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
